{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:09:14Z","timestamp":1785798554065,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.4158\/ep10211.cr","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T11:20:09Z","timestamp":1295436009000},"page":"e37-e42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Parathyroid carcinoma arising from four-gland hyperplasia"],"prefix":"10.1016","volume":"17","author":[{"given":"Rondi M.","family":"Kauffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel E.","family":"Fohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Broome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Phay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP10211.CR_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2559.2006.02380.x","article-title":"Prognostic and predictive factors in endocrine tumours","volume":"48","author":"Stephenson","year":"2006","journal-title":"Histopathology"},{"key":"10.4158\/EP10211.CR_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4615-6355-6_9","article-title":"Parathyroid carcinoma","volume":"89","author":"Sandelin","year":"1997","journal-title":"Cancer Treat Res"},{"key":"10.4158\/EP10211.CR_bb0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","article-title":"Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification","volume":"14","author":"Juhlin","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP10211.CR_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","article-title":"Loss of parafibromin expression in a subset of parathyroid adenomas","volume":"13","author":"Juhlin","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP10211.CR_bb0030","first-page":"481","article-title":"Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas","volume":"34","author":"Juhlin","year":"2009","journal-title":"Int J Oncol"},{"key":"10.4158\/EP10211.CR_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.cco.0000198019.53606.2b","article-title":"Parathyroid carcinoma","volume":"18","author":"Rodgers","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.4158\/EP10211.CR_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: parathyroid carcinoma","volume":"86","author":"Shane","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10211.CR_bb0045","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","article-title":"Histopathological variables and DNA cytometry in parathyroid carcinoma","volume":"17","author":"Bondeson","year":"1993","journal-title":"Am Surg Pathol"},{"key":"10.4158\/EP10211.CR_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00132583-200301000-00006","article-title":"Parathyroid pathology: a practical approach","volume":"8","author":"Cheung","year":"2003","journal-title":"Pathol Case Rev"},{"key":"10.4158\/EP10211.CR_bb0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000658-198104000-00006","article-title":"Surgical resection of metastatic parathyroid carcinoma","volume":"193","author":"Flye","year":"1981","journal-title":"Ann Surg"},{"key":"10.4158\/EP10211.CR_bb0060","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.4158\/EP10211.CR_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1309\/9NXP7FRF87MU2PCK","article-title":"Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions","volume":"126","author":"Saggiorato","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.4158\/EP10211.CR_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199403173301105","article-title":"Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma","volume":"330","author":"Cryns","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4158\/EP10211.CR_bb0075","first-page":"599","article-title":"Genomic localization of novel candidate tumor suppressor gene loci in parathyroid adenomas","volume":"56","author":"Tahara","year":"1996","journal-title":"Cancer Res"},{"key":"10.4158\/EP10211.CR_bb0080","first-page":"1006","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"key":"10.4158\/EP10211.CR_bb0085","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.4158\/EP10211.CR_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"key":"10.4158\/EP10211.CR_bb0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0002-9610(85)80050-7","article-title":"Natural history of parathyroid carcinoma: diagnosis, treatment, and results","volume":"149","author":"Wang","year":"1985","journal-title":"Am J Surg"},{"key":"10.4158\/EP10211.CR_bb0100","first-page":"1095","article-title":"Parathyroid carcinoma: the Lahey Clinic experience","volume":"98","author":"Cohn","year":"1985","journal-title":"Surgery"},{"key":"10.4158\/EP10211.CR_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/014556130208100611","article-title":"Primary hyperparathyroidism secondary to simultaneous bilateral parathyroid carcinoma","volume":"81","author":"Brown","year":"2002","journal-title":"Ear Nose Throat J"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/9TR8433176745745.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:51:50Z","timestamp":1761515510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20422591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1530891X20422591"],"URL":"https:\/\/doi.org\/10.4158\/ep10211.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid carcinoma arising from four-gland hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10211.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}